SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (298)12/29/2002 12:26:12 AM
From: scaram(o)uche   of 469
 
USE OF GLUCOSYLCERAMIDE SYNTHESIS INHIBITORS IN BRAIN CANCERTHERAPY
Patent Number:
Publication date: 2002-12-11
Inventor(s): SEYFRIED THOMAS N (GB); PLATT FRANCES M (GB); SMITH PAUL DAVID (GB)
Applicant(s): OXFORD GLYCOSCIENCES UK LTD (GB); UNIV OXFORD (GB)
Requested Patent: EP1263436
Application Number: EP20010911967 20010319
Priority Number(s): WO2001GB01189 20010319; GB20000006539 20000317

(no link/abstract yet)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News